Announcements

Removal of Component(s) – SRNE

February 13, 2023

LifeSci Biotechnology Clinical Trials Index

Effective at the market close on Monday, February 13, 2023, SRNE will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights.

On February 13, 2023, Sorrento Therapeutics indicated it had filed for Chapter 11 bankruptcy. As a result, SRNE no longer qualifies for inclusion in the Index.